Navigation Links
New remedy for those suffering from Crohn's disease

Crohn's disease is an often debilitating, lifelong gastrointestinal illness that usually shows up when people are in their 20s or 30s. The disease leaves one too fatigued even to perform daily activities or it causes severe abdominal pain. However, treatments available currently do not help all patients suffering from the disease. Now, Dr. Brian Dieckgraefe, M.D., Ph.D, a gastroenterologist at Washington University in St. Louis, is offering a new cure to Crohn's// patients, which he claims is the polar opposite of what currently available drugs are offering. The drug called GM-CSF, which stands for granulocyte-macrophage colony stimulating factor and also known as Leukine, stimulates the immune system instead of suppressing it. Dr. Dieckgraefe claims that 80 per cent of people showed relief from symptoms while 53 per cent treated went into remission. GM-CSF is given by self-injection once a day.

The drug is going through a larger second phase of study and so is not available commercially as yet. The drug, though not approved for treatment of Crohn's has FDAs approval for other uses.


'"/>




Page: 1

Related medicine news :

1. A remedy to overcome dandruff
2. FDA panel refuses anti-viral cold remedy
3. A remedy to lessen fatigue
4. Now art comes as a remedy and aid to GPs.
5. Simple remedy to prevent DVT: Eat 6 Tomatoes!
6. Risk of DVT for those spending long hours in front of computers
7. A word of caution issued by the FDA for those using antipsychotic drugs for dementia
8. Watch out those of you planning for a predetermined Cesarean Section
9. Good news for those of you wanting to live longer
10. A pill for those who live to eat !
11. Finally, light at the end of the tunnel for those suffering tunnel vision

Post Your Comments:
(Date:11/29/2009)... Traditional healthcare,s...or viable affordable alternative care. Affordable ... (PRWEB) November 29, 2009 -- Aff...une of this year (2009) and has been met with enth...d rapid success can be attributed to two things, n...
(Date:11/28/2009)..., , CHICAGO, Nov. 28 Ge...mon practice in the clinical routine when Siem...ientific Assembly and Annual Meeting of the Radiol...er 29 to December 3 at McCormick Place (Booth #825...o. With syngo. via , Siemens, new imaging ...
(Date:11/28/2009)...Study finds gene variation believed to affect circ...HealthDay News) -- New research suggests that an i... a factor in the development of bipolar disorder i...mination of the genetic makeup of 152 children wit...ble to major mood swings, and 140 children without...
(Date:11/27/2009)..., , BEDFORD, Mass., Nov. 27 /PRNewswire-F...he "Company"), a supplier of precision technology ...d that an annual meeting of the Company,s sharehol.... The time and location of the meeting will be an...he Company received a requisition notice from Step...
(Date:11/27/2009)... Biotech firm Replikins L...f the H1N1 virus genomic data. It shows that the ...f 3.7 (s.d. 4.5) during the virus,s current outbre...evels this week of 2.0 (s.d. 0.1). The H1N1 infect... Boston (PRWEB) November 27, 2009...
Breaking Medicine News(10 mins):Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5
...3 times faster, dramatically boosting survival , ...searchers report they have dramatically increased ...y bleeding within the brain by fine-tuning the dos...in patients with this condition to an 80 percent s...
...ry teacher, hits five cities in one ... Rosenthal, founder and primary,teacher of the Ins...est,nutrition school, is hosting a public lecture ...lso discuss the,challenges and opportunities that ...
...onsumption may,promote cancer-preventive effects i...ing the medical treatment of some kinds of cancer,...f Alternative Therapies in Health and,Medicine, on...ncerous,adjacent human gastric tissues and 7 cance...
...physicians,researchers, Wall Street analysts and i... Resort for THE Aesthetic Show, May 30 - June 1, 2...edical aesthetic educational,program ever assemble..."THE Aesthetic Show offers a weekend immersion in ...
...s to ,Green, Packaging, CASTLE ROCK, Colo., May 1... retailer, has announced that it will replace its,...g that is completely,reusable, functional, and eco....com, said, "We believe that,every company has an ...
...rrelates with Age, KYOTO, Japan, May 14 New rese...ses of aging has identified a previously,unknown s...rom external,triggers, such as sun exposure and ci...s from Nu Skin Enterprises and Purdue University r...
Other Medicine News:Health News:Clot-Busting Treatment Improves Bleeding Stroke Outcomes 2Health News:Institute for Integrative Nutrition Begins Road Tour 2Health News:Study Suggests Green Tea May Support the Medical Treatment of Stomach and Colon Cancer 2Health News:THE Aesthetic Show Advances $34 Billion Market 2Health News:THE Aesthetic Show Advances $34 Billion Market 3Health News:CoffeeCakes.com Has Recycling 'In the Bag' 2Health News:Nu Skin Scientists Identify Additional Free Radical Generator 2Health News:Nu Skin Scientists Identify Additional Free Radical Generator 3
(Date:11/25/2009)..., RANCHO CORDOVA, Calif., Nov. 25 /PRNewswire/ -...American Pacific Corporation (Nasdaq: APFC ) anno...ponsibility and Sustainability Award at the Annual...California Manufacturers and Technology Associatio... (IEA) and the Chemical Industry Council of Califo...
(Date:11/25/2009)... , HARBIN, China, Nov. 25 /PRNewswire-As...na Sky One Medical" or "the Company") (Nasdaq: CS...mpany developing and producing,over-the-counter dr...ay,announced that the Company recently passed the ...maceutical and Biological Products ("ICPBP") exami...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Report...port is available in its catalogue: ,, Mammog..., http://www.reportlinker.com/p0164330/Mammogra...,, Rising incidence of breast cancer in industr...al factor influencing growth in the mammography ma...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8VBI awarded 2427 million from NIH to support infectious disease research 10266 1VBI awarded 2427 million from NIH to support infectious disease research 10266 2VBI awarded 2427 million from NIH to support infectious disease research 10266 3VBI awarded 2427 million from NIH to support infectious disease research 10266 4Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 1Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 2Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 3 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 1 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 2 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 3 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 4 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 5 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 6
...ieved at Least 75 Percent Improvement in Psoriasis...sing Groups, More,Than Half Achieved 90 Percent Im...wire-FirstCall/ -- New,Phase II study results show...ced psoriasis symptoms significantly in the majori...0 patients with,moderate to severe psoriasis achie...
...nd, 4th May 2007 - CeNeS Pharmaceuticals plc,(LSE:...ny, notes,the publication of an independent study ...its Phase II NMDA antagonist, CNS 5161. CeNeS,is d...uropathic,pain. The independent study builds on th...5161. , In the study reported in ,Synapse, Dr Ana...
Other Medicine Technology:Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 2Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 3Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 4Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3
EDM Ventricular Drainage Kit, with Drip Chamber
Lumbar External Drainage System (LED)
Monitorr ICP External CSF Drainage and Monitoring System
Skull Traction Tongs
Medicine Products: